Rapport Therapeutics (RAPP) Non Operating Income (2023 - 2026)
Rapport Therapeutics (RAPP) posted Non Operating Income of $4.19 million for Q2 2026, up 51.6% from $2.76 million a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Non Operating Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Rapport Therapeutics was $16.36 million, up 21.6% year-over-year; for FY2025, it came in at $13.62 million, up 186.8% from FY2024.
- In prior years, Rapport Therapeutics' Non Operating Income was $4.75 million in FY2024 (+238.4%) and $1.4 million in FY2023.
- Quarterly Non Operating Income has run from a low of -$5.58 million in Q1 2024 to a high of $4.75 million in Q4 2025 over five years.
- On a year-over-year basis, Non Operating Income has increased in each of the last three quarters, with growth averaging 94.6% over the last seven quarters.
- According to Business Quant data, Non Operating Income for the three prior quarters was $4.36 million (Q1 2026), $4.75 million (Q4 2025) and $3.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Rapport Therapeutics | 1.27 Bn | 876.60 Mn | - | 3.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.85 Mn |
| Jun 30, 2026 | 4.19 Mn |
| Mar 31, 2026 | 4.36 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | -5.58 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 221,000.00 |
API Access
Rapport Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();